Gerald D. Cagle is Director at AERIE PHARMACEUTICALS INC (AERI). They have made 13 open-market trades across 2 companies since 2014, most recently 2021-06-17.
CIK 0001589991
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
11 open-market purchases totalling $793K since 2014, against 2 sales. Across 11 scored buys the stock is up 11.3% at ninety days, and 7.2 points ahead of the S&P over the same stretch.
11 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 45% | 55% | 73% |
| Avg Move | +2.8% | +6.2% | +11.3% |
| Alpha | +2.3% | +5.9% | +7.2% |
| Scored | 11 | 11 | 11 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| AERI | SELL | 2020-05-08 | 2020-05-12 | $15.27 | $76K | +1.3% | -14.6% | -17.1% |
| AERI | BUY | 2018-11-16 | 2018-11-19 | $41.75 | $84K | -8.8% | -18.2% | -6.7% |
| AERI | BUY | 2018-05-25 | 2018-05-25 | $49.45 | $49K | +31.6% | +37.6% | +22.7% |
| AERI | BUY | 2018-05-21 | 2018-05-22 | $50.25 | $50K | +12.8% | +34.6% | +27.5% |
| CLSD | BUY | 2018-03-22 | 2018-03-23 | $11.89 | $89K | -12.9% | -5.3% | -12.8% |
| CLSD | BUY | 2017-08-11 | 2017-08-15 | $7.08 | $35K | -3.4% | +7.4% | +5.1% |
| AERI | BUY | 2017-05-09 | 2017-05-17 | $39.90 | $40K | +44.5% | +30.3% | +36.5% |
| AERI | BUY | 2017-04-19 | 2017-04-20 | $41.70 | $83K | -0.4% | -2.8% | +30.4% |
| CLSD | BUY | 2017-03-27 | 2017-05-01 | $7.10 | $200K | +4.3% | -16.9% | +4.1% |
| CLSD | BUY | 2017-03-16 | 2017-03-20 | $6.84 | $34K | +7.0% | +3.9% | +15.0% |
| CLSD | SELL | 2016-06-07 | 2016-06-07 | $7.00 | $14 | +1.4% | -3.0% | +15.8% |
| AERI | BUY | 2015-02-04 | 2016-04-26 | $17.86 | $100K | -18.4% | +0.4% | +4.9% |
| AERI | BUY | 2014-05-16 | 2014-05-20 | $15.07 | $28K | -25.9% | -2.5% | -2.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.